ATE415388T1 - Verfahren zur herstellung von enantiomerenreinen 4-pyrrolidinophenyl- benzyletherderivaten - Google Patents
Verfahren zur herstellung von enantiomerenreinen 4-pyrrolidinophenyl- benzyletherderivatenInfo
- Publication number
- ATE415388T1 ATE415388T1 AT06707355T AT06707355T ATE415388T1 AT E415388 T1 ATE415388 T1 AT E415388T1 AT 06707355 T AT06707355 T AT 06707355T AT 06707355 T AT06707355 T AT 06707355T AT E415388 T1 ATE415388 T1 AT E415388T1
- Authority
- AT
- Austria
- Prior art keywords
- pyrrolidinophenyl
- ether derivatives
- benzyl ether
- enantiomer pure
- producing enantiomer
- Prior art date
Links
- YOVMEQZKFWKEAI-UHFFFAOYSA-N 1-[4-[phenyl-[phenyl-(4-pyrrolidin-1-ylphenyl)methoxy]methyl]phenyl]pyrrolidine Chemical class C1CCCN1C1=CC=C(C(OC(C=2C=CC=CC=2)C=2C=CC(=CC=2)N2CCCC2)C=2C=CC=CC=2)C=C1 YOVMEQZKFWKEAI-UHFFFAOYSA-N 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05102028 | 2005-03-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE415388T1 true ATE415388T1 (de) | 2008-12-15 |
Family
ID=36218379
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06707355T ATE415388T1 (de) | 2005-03-15 | 2006-03-02 | Verfahren zur herstellung von enantiomerenreinen 4-pyrrolidinophenyl- benzyletherderivaten |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US7485731B2 (de) |
| EP (1) | EP1861362B1 (de) |
| JP (1) | JP4796620B2 (de) |
| KR (1) | KR100915736B1 (de) |
| CN (1) | CN101142181B (de) |
| AT (1) | ATE415388T1 (de) |
| AU (1) | AU2006224878B2 (de) |
| BR (1) | BRPI0608466A2 (de) |
| CA (1) | CA2601416C (de) |
| DE (1) | DE602006003879D1 (de) |
| ES (1) | ES2314877T3 (de) |
| IL (1) | IL185635A (de) |
| MX (1) | MX2007011154A (de) |
| TW (1) | TW200640856A (de) |
| WO (1) | WO2006097197A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2016118748A (ru) * | 2013-10-29 | 2017-12-05 | Ф. Хоффманн-Ля Рош Аг | Кристаллические формы производного пирролидона, полезные при лечении болезни альцгеймера, и их получение |
| WO2016156124A1 (en) | 2015-03-27 | 2016-10-06 | F. Hoffmann-La Roche Ag | Pharmaceutical formulation comprising sembragiline |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3258027B2 (ja) | 1996-03-15 | 2002-02-18 | サマーセット・ファーマシューティカルズ・インコーポレイテッド | セレジリン投与による末梢ニューロパシーの予防および治療方法 |
| AU1359801A (en) | 1999-11-05 | 2001-06-06 | Vela Pharmaceuticals Inc. | Methods and compositions for treating reward deficiency syndrome |
| MY134480A (en) * | 2002-09-20 | 2007-12-31 | Hoffmann La Roche | 4-pyrrolidino-phenyl-benzyl ether derivatives |
-
2006
- 2006-03-02 MX MX2007011154A patent/MX2007011154A/es active IP Right Grant
- 2006-03-02 AU AU2006224878A patent/AU2006224878B2/en not_active Ceased
- 2006-03-02 WO PCT/EP2006/001878 patent/WO2006097197A1/en not_active Application Discontinuation
- 2006-03-02 CN CN2006800082128A patent/CN101142181B/zh not_active Expired - Fee Related
- 2006-03-02 AT AT06707355T patent/ATE415388T1/de active
- 2006-03-02 ES ES06707355T patent/ES2314877T3/es active Active
- 2006-03-02 JP JP2008501182A patent/JP4796620B2/ja not_active Expired - Fee Related
- 2006-03-02 EP EP06707355A patent/EP1861362B1/de not_active Not-in-force
- 2006-03-02 DE DE602006003879T patent/DE602006003879D1/de active Active
- 2006-03-02 CA CA2601416A patent/CA2601416C/en not_active Expired - Fee Related
- 2006-03-02 KR KR1020077020948A patent/KR100915736B1/ko active IP Right Grant
- 2006-03-02 BR BRPI0608466-4A patent/BRPI0608466A2/pt not_active Application Discontinuation
- 2006-03-08 US US11/370,450 patent/US7485731B2/en not_active Expired - Fee Related
- 2006-03-13 TW TW095108442A patent/TW200640856A/zh unknown
-
2007
- 2007-08-30 IL IL185635A patent/IL185635A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| KR100915736B1 (ko) | 2009-09-04 |
| ES2314877T3 (es) | 2009-03-16 |
| US20060211869A1 (en) | 2006-09-21 |
| EP1861362A1 (de) | 2007-12-05 |
| KR20070103494A (ko) | 2007-10-23 |
| TW200640856A (en) | 2006-12-01 |
| AU2006224878B2 (en) | 2011-02-17 |
| AU2006224878A1 (en) | 2006-09-21 |
| WO2006097197A1 (en) | 2006-09-21 |
| CA2601416C (en) | 2013-07-09 |
| JP4796620B2 (ja) | 2011-10-19 |
| US7485731B2 (en) | 2009-02-03 |
| BRPI0608466A2 (pt) | 2010-01-05 |
| MX2007011154A (es) | 2007-10-17 |
| IL185635A0 (en) | 2008-01-06 |
| EP1861362B1 (de) | 2008-11-26 |
| DE602006003879D1 (de) | 2009-01-08 |
| IL185635A (en) | 2011-07-31 |
| CN101142181A (zh) | 2008-03-12 |
| CN101142181B (zh) | 2011-05-04 |
| JP2008533061A (ja) | 2008-08-21 |
| CA2601416A1 (en) | 2006-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA99896C2 (uk) | Спосіб одержання глюкопіранозилзаміщених похідних бензилбензолу, проміжні продукти та способи їх одержання | |
| EA200901529A1 (ru) | Производные арилоазол-2-илцианоэтиламина, способ их получения и способ их применения | |
| ATE430480T1 (de) | Verfahren zur herstellung von nährmittelzusammensetzungen | |
| ATE526312T1 (de) | Verfahren zur herstellung von reinen 4- pyrrolidinophenylbenzyletherderivaten als maob- inhibitoren | |
| ATE425136T1 (de) | Verfahren zur herstellung substituierter 3-aryl- butyl-aminverbindungen | |
| ATE542803T1 (de) | Verfahren zur herstellung von dihydrochinazolinen | |
| ATE552230T1 (de) | Verfahren zur herstellung von derivaten aus 1-(2- halobiphenyl-4-yl)-cyclopropancarboxylsäure | |
| ATE486857T1 (de) | Verfahren zur herstellung von telmisartan | |
| EA201100759A1 (ru) | Арилоазол-2-илцианоэтиламиносоединения противопаразитарного действия, обогащенные одним из энантиомеров | |
| ATE506352T1 (de) | Verfahren zur herstellung von optional 2- substituierten 1,6-dihydro-6-oxo-4- pyrimidincarboxylsäuren | |
| MX2009003257A (es) | Procedimiento para la sintesis de derivados de fenoxi diaminopirimidina. | |
| ATE539054T1 (de) | Verfahren zur herstellung von dihydropyrrolderivaten als zwischenprodukte | |
| ATE473955T1 (de) | Verfahren zur herstellung von angereichertem isopulegol | |
| ATE489352T1 (de) | Verfahren zur herstellung von brenztraubensäure | |
| ATE447567T1 (de) | Verfahren zur herstellung von tryptase- inhibitoren | |
| DE502005007702D1 (de) | Verfahren zur herstellung von terrylen-3,4:11,12-t | |
| ATE506342T1 (de) | Ein verfahren zur herstellung von tolterodin | |
| ATE529413T1 (de) | Verfahren zur synthese von aryloxydiaminopyrimidinen | |
| ATE466003T1 (de) | Herstellung von 2-aminothiazol-5- carbonsäurederivaten | |
| DK2060568T3 (da) | Polymorfer af enantiomerisk ren erdostein | |
| DE102005054282A1 (de) | Verfahren zur Herstellung von überwiegend ein Enantiomer enthaltendem 1,1,1-Trifluorisopropanol | |
| ATE415388T1 (de) | Verfahren zur herstellung von enantiomerenreinen 4-pyrrolidinophenyl- benzyletherderivaten | |
| ATE549315T1 (de) | Verfahren zur herstellung von kristallinem perindopril | |
| TW200700369A (en) | Process for enantioselective synthesis of single enantiomers of thio-substituted arylmethanesulfinyl derivatives by asymmetric oxidation field of the invention | |
| ATE423775T1 (de) | Verfahren zur herstellung von lactonen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1861362 Country of ref document: EP |